Found 5 matching trials
A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.
PHASE1To Investigate the safety and immunologic activity of AGS-004, an autologou...
Location
Immunodeficiency Service/Montreal Chest Institute
Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
PHASE2The purpose of this study is to examine the ability of AGS-004 to control H...
Location
Practice Comprehensive Care Practice Div of Onfectious Disease & HIV Med
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
PHASE1The purpose of this research study is to 1) evaluate the safety of a series...
Location
University of North Carolina Hospitals
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
PHASE2The purpose of this study is to determine the safety and effectiveness of A...
Location
UCDavis Research Office at CARES
A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
PHASE1The purpose of this study is to:
* find out the intensity and duration of ...
Location
University of North Carolina